featured
Cemiplimab Induces Response in Advanced Cutaneous SCC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
PD-1 Blockade With Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma
N. Engl. J. Med 2018 Jun 04;[EPub Ahead of Print], MR Migden, D Rischin, CD Schmults, A Guminski, A Hauschild, KD Lewis, CH Chung, L Hernandez-Aya, AM Lim, ALS Chang, G Rabinowits, AA Thai, LA Dunn, BGM Hughes, NI Khushalani, B Modi, D Schadendorf, B Gao, F Seebach, S Li, J Li, M Mathias, J Booth, K Mohan, E Stankevich, HM Babiker, I Brana, M Gil-Martin, J Homsi, ML Johnson, V Moreno, J Niu, TK Owonikoko, KP Papadopoulos, GD Yancopoulos, I Lowy, MG FuryFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.